Collectively, our data now reveal that intravenous iron supplementation with FCM results in early endothelial dysfunction with increased release of CD62E- and CD54-expressing EMVs and consecutive promotion of vascular repair mediated by mobilization of regenerative EPCs. This evidence concerns the gene ICAM1 and endothelial dysfunction.